Navigation Links
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Date:11/30/2011

NEW YORK, Nov. 30, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cardiovascular Drug Delivery - technologies,markets and companies

http://www.reportlinker.com/p0203538/Cardiovascular-Drug-Delivery---technologiesmarkets-and-companies.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

Summary

Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood and nutrients to all organs of the body. Drugs can be introduced into the vascular system for systemic effects or targeted to an organ via the regional blood supply. In addition to the usual formulations of drugs such as controlled release, devices are used as well. This report starts with an introduction to molecular cardiology and discusses its relationship to biotechnology and drug delivery systems.

Drug delivery to the cardiovascular system is approached at three levels: (1) routes of drug delivery; (2) formulations; and finally (3) applications to various diseases. Formulations for drug delivery to the cardiovascular system range from controlled release preparations to delivery of proteins and peptides. Cell and gene therapies, including antisense and RNA interference, are described in full chapters as they are the most innovative methods of delivery of therapeutics. Various methods of improving systemic administration of drugs for cardiovascular disorders are described including use of nanotechnology.

Cell-selective targeted drug delivery h
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cynosure to Present at Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Conference
2. CryoLife to Present at 6th Annual Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference
3. New Analysis of Data Presented at AHA Regarding Effect of Effient® (Prasugrel) on Cardiovascular Events in STEMI Patients According to Timing of PCI
4. The Global Cardiovascular Monitoring & Diagnostic Devices Market is Booming: Expected to Attain a Market Size of USD 1.3 Billion by 2016
5. MAQUET Cardiovascular Announces FDA 510(k) Clearance and CE Mark for the CARDIOSAVE™ Intra-Aortic Balloon Pump
6. CVS Caremark Launches Chronic Cardiovascular Disease Medication Adherence Program
7. MAQUET Cardiovascular Completes Acquisition of Atrium Medical Corporation
8. Beating Cardiovascular Disease: Continuing Medical Education Course (CME) in Jackson, MS
9. MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
10. DMC Cardiovascular Institute Physician is First in Michigan to Use New "Arterial Drill" Catheterization Technique to Remove a Major Blockage
11. Global Cardiovascular Drug Market: Strategic Assessments of Leading Suppliers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... Conference, to be held March 8-11, 2015, in ... James Sapirstein , Chief Executive Officer, will provide an ... and will be available to participate in one-on-one meetings ...
(Date:3/5/2015)... 2015 Hitachi Medical Systems ... OASIS *    at ECR 2015 - the ... set a benchmark for patient-centric care. The new features ... whilst optimizing workflow management and costs. OASIS demonstrates the ... for imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and ...
(Date:3/5/2015)... PARK, Calif. , March 5, 2015  Asterias ... in the emerging field of regenerative medicine, announced today ... of the nation,s top rehabilitation hospitals for spinal cord ... Phase 1/2a clinical trial of AST-OPC1 (oligodendrocyte progenitor cells) ... cervical spinal cord injury (SCI). The ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4
... Medarex, Inc. (Nasdaq:, MEDX ) announced today ... non-fucosylated version of MDX-060 that targets CD30, a,marker ... malignant cells of,Hodgkin,s lymphoma (HL) as well as ... potency and efficacy in cell lines when,compared to ...
... TEL AVIV, Israel, December 8 InspireMD, Ltd. announced,that ... use in Israel,by the Israeli Ministry of Health. , ... system presents a novel combination of a coronary,stent merged ... by an expandable, flexible fishnet style, micron level knit,sleeve ...
Cached Medicine Technology:Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma 2Medarex Announces Enhanced Activity Data with Second Generation Anti-CD30 Antibody for Malignant Lymphoma 3MGuard(TM) Coronary Stent System Approved in Israel 2MGuard(TM) Coronary Stent System Approved in Israel 3
(Date:3/5/2015)... IL (PRWEB) March 05, 2015 The ... announce their sponsorship of the upcoming Crain’s Chicago Business ... , The Physicians' Breakfast will take place from 7:30 ... East Pearson Street, Chicago, IL 60611. The morning’s events ... Chicago’s top healthcare professionals. , The panel discussion ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Colorful packaging ... breakfast cereals are best for health. But all it ... what to look for, reports the March 2015 ... a plan," says Kathy McManus, director of the Department ... for a cereal that hits all the markers of ...
(Date:3/5/2015)... 2015 Considering egg freezing? Atlanta Center ... holding an informational event on March 30, ... future families with egg freezing. , What: Egg Freezing ... Rd, Atlanta, GA, Time: 5:30 - 7:30 PM, Date: ... Register here ! , In response to the ...
(Date:3/5/2015)... Plains, NY (PRWEB) March 05, 2015 Hope ... New York Sporting Clay Shoot to be held at Beretta ... May 15, 2015. All proceeds from the event will benefit ... a sense of self, restoring the family unit, and restoring ... The event will honor our nation’s heroes through a day ...
(Date:3/5/2015)... NE (PRWEB) March 05, 2015 Aureus ... staffing, including locum tenens and direct hire physician jobs, ... at the Nebraska Academy of Family Physicians 67th Annual ... 2015 in La Vista, Nebraska. , The Annual ... ways to learn, networking opportunities, and an exhibition of ...
Breaking Medicine News(10 mins):Health News:Cook County Law Firm to Sponsor Physicians Breakfast 2Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 2Health News:Egg Freezing Seminar Allows Women to Pause the Biological Clock for Age, Social or Medical Reasons 3Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2Health News:Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the Nebraska Academy of Family Physicians Annual Meeting & Scientific Assembly 2
... WORTH, Texas, April 21 A company known for,standing ... a step toward,saving the lives of premature babies over ... the Tarrant County effort,to support the 2008 March of ... The March for Babies is a nationwide campaign that ...
... not everyone who is bitten by a malaria-infected mosquito ... the University of Toronto. , Malaria causes an estimated ... headache, high fevers and nausea to more than 1 ... a major effect on the evolution of our species. ...
... Fund Corp.,(OTC:MXFD), is pleased to announce that Mr. Dan ... been appointed to the Board of Directors of,the Company., ... Mr. Schmitt brings with,him, his vast experience and entrepreneurial ... board members since September 2007, we,are very pleased that ...
... wonder giving relief to ... incontinence patients worldwide, DETROIT, April 21 ... new agreement with HANMEDICS, a,Korea-based medical device company recognized for ... their first glimpse of the,"wonder-machine," acclaimed world-wide, known as the ...
... French . , Montreal, April 21, ... cells communicate has just been discovered by the team ... the McGill University Health Centre (MUHC) in collaboration with ... cells are able to communicate with their more healthy ...
... to Speak, CLEVELAND, April 21 Recovery Resources ... and drug,addiction agencies, will hold its 2008 Annual Meeting ... Windows on the River in the Powerhouse Building,in the ... of,Children,s Programs at the Betty Ford Center. His address ...
Cached Medicine News:Health News:MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors 2Health News:MaxLife Fund Corp. Appoints Mr. Dan Schmitt, Mr. Randy Delkus and Mr. Daniel E. Kahan to its Board of Directors 3Health News:Medical Breakthrough Reaches America 2Health News:Cancer cells spread by releasing 'bubbles', according to an MUHC study 2Health News:Focus on Children of Alcoholics at Addiction Agency's Annual Meeting 2
Engineered for high volume surgical efficiencies, the Bausch & Lomb Hansatome Microkeratome, a corneal resection instrument, features an automated pivoting motion that provides smooth, resistance-fre...
... The Brilliance 64-channel configuration breaks through ... large volume, thin-slice coverage to improve ... , ,With 40mm of thin-slice coverage, ... imaging, allowing for unprecedented coronary artery ...
Assay for Anti-HTLV-I and Anti-HTLV-II...
InBios' Trypanosoma cruzi (chagas disease) is an ELISA system for the detection of antibodies to T.cruzi derived TcF antigen in human serum or plasma This test is intended for professional in vitro d...
Medicine Products: